Small Molecule Inhibitors of HSF1-Activated Pathways as Potential Next-Generation Anticancer Therapeutics

Targeted therapy is an emerging paradigm in the development of next-generation anticancer drugs. Heat shock factor 1 (HSF1) has been identified as a promising drug target because it regulates several pathways responsible for cancer cell growth, metastasis, and survival. Studies have clearly demonstr...

Full description

Bibliographic Details
Main Authors: Chiranjeev Sharma, Young Ho Seo
Format: Article
Language:English
Published: MDPI AG 2018-10-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/23/11/2757
_version_ 1819080142460289024
author Chiranjeev Sharma
Young Ho Seo
author_facet Chiranjeev Sharma
Young Ho Seo
author_sort Chiranjeev Sharma
collection DOAJ
description Targeted therapy is an emerging paradigm in the development of next-generation anticancer drugs. Heat shock factor 1 (HSF1) has been identified as a promising drug target because it regulates several pathways responsible for cancer cell growth, metastasis, and survival. Studies have clearly demonstrated that HSF1 is an effective drug target. Herein, we provide a concise yet comprehensive and integrated overview of progress in developing small molecule inhibitors of HSF1 as next-generation anticancer chemotherapeutics while critically evaluating their potential and challenges. We believe that this review will provide a better understanding of important concepts helpful for outlining the strategy to develop new chemotherapeutic agents with promising anticancer activities by targeting HSF1.
first_indexed 2024-12-21T19:40:11Z
format Article
id doaj.art-b922eb3ce4d44da7901fbe038c2cdf31
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-12-21T19:40:11Z
publishDate 2018-10-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-b922eb3ce4d44da7901fbe038c2cdf312022-12-21T18:52:30ZengMDPI AGMolecules1420-30492018-10-012311275710.3390/molecules23112757molecules23112757Small Molecule Inhibitors of HSF1-Activated Pathways as Potential Next-Generation Anticancer TherapeuticsChiranjeev Sharma0Young Ho Seo1College of Pharmacy, Keimyung University, Daegu 42601, KoreaCollege of Pharmacy, Keimyung University, Daegu 42601, KoreaTargeted therapy is an emerging paradigm in the development of next-generation anticancer drugs. Heat shock factor 1 (HSF1) has been identified as a promising drug target because it regulates several pathways responsible for cancer cell growth, metastasis, and survival. Studies have clearly demonstrated that HSF1 is an effective drug target. Herein, we provide a concise yet comprehensive and integrated overview of progress in developing small molecule inhibitors of HSF1 as next-generation anticancer chemotherapeutics while critically evaluating their potential and challenges. We believe that this review will provide a better understanding of important concepts helpful for outlining the strategy to develop new chemotherapeutic agents with promising anticancer activities by targeting HSF1.https://www.mdpi.com/1420-3049/23/11/2757HSF1HSPsHSF1 inhibitorsanticancer agents
spellingShingle Chiranjeev Sharma
Young Ho Seo
Small Molecule Inhibitors of HSF1-Activated Pathways as Potential Next-Generation Anticancer Therapeutics
Molecules
HSF1
HSPs
HSF1 inhibitors
anticancer agents
title Small Molecule Inhibitors of HSF1-Activated Pathways as Potential Next-Generation Anticancer Therapeutics
title_full Small Molecule Inhibitors of HSF1-Activated Pathways as Potential Next-Generation Anticancer Therapeutics
title_fullStr Small Molecule Inhibitors of HSF1-Activated Pathways as Potential Next-Generation Anticancer Therapeutics
title_full_unstemmed Small Molecule Inhibitors of HSF1-Activated Pathways as Potential Next-Generation Anticancer Therapeutics
title_short Small Molecule Inhibitors of HSF1-Activated Pathways as Potential Next-Generation Anticancer Therapeutics
title_sort small molecule inhibitors of hsf1 activated pathways as potential next generation anticancer therapeutics
topic HSF1
HSPs
HSF1 inhibitors
anticancer agents
url https://www.mdpi.com/1420-3049/23/11/2757
work_keys_str_mv AT chiranjeevsharma smallmoleculeinhibitorsofhsf1activatedpathwaysaspotentialnextgenerationanticancertherapeutics
AT younghoseo smallmoleculeinhibitorsofhsf1activatedpathwaysaspotentialnextgenerationanticancertherapeutics